PROFESSIONAL EDITION

The largest community of pharma leaders

Trialbee Announces the Release of HIVE, the Smartest Way to Leverage Real-World Data in Patient Recruitment

RESEARCH TRIANGLE PARK, N.C. & MALMÖ, Sweden–(BUSINESS WIRE)–Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced the release of HIVE™, a smart data science application applied on Real World Data (RWD) to enhance targeting and precision in performance-driven patient recruitment for global clinical trials.

“Traditional patient recruitment has limited access to patients and takes a long time to accomplish. Digital advertising for clinical trials, to supplement the pool of patients available to investigators, often results in large burdensome screening activities for the sites only to result in a few additional patients to enroll. Trialbee HIVE uses a smart modeling technique and expands the pool of potential clinical trial participants and then narrows down the pool to only the most relevant candidates matching the study criteria. The multi-sourcing of patients from large RWD repositories provides sites with a steady flow of motivated and study-ready patients allowing sites to focus on the final clinical evaluation prior to enrollment,” said Lollo Eriksson, Chief Strategy Officer at Trialbee.

Trialbee HIVE is a result of combined expertise and close collaboration with Trialbee partner organizations specializing in global health research networks, RWD management, advanced data science techniques, consumer data connectivity platforms and eClinical technologies. “We are proud of the integration work between these innovative institutions and organizations, and to be able to offer Trialbee HIVE to sponsors, clinical research organizations and investigators engaged in clinical research,” said Matt Walz, CEO of Trialbee.

“The ability to simulate an eligible cohort with RWD and safely connect, qualify and scale with measurable outcomes is a critical step to achieve the precision needed to understand and target the patient population for a trial. A steppingstone capability to strategic clinical study management and improvement of the recruitment approach is to use this information to access and engage a large number of patients using smart matching techniques to ensure a diverse study population,” said Mats Sundgren, Director of Health Informatics, Astra Zeneca.

The most prescient challenges facing pharmaceutical research & development (R&D) are slow patient recruitment and large numbers of dropouts from clinical trials, causing significant delays and increasing costs for pharmaceutical products to reach the marketplace. The Trialbee solution is designed to manage and accelerate the patient recruitment process and maintain patient engagement by incorporating data-driven digital solutions in clinical trials and optimizing protocol design and site selection.

For more information on how HIVE can improve your trial’s patient recruitment and engagement, visit https://trialbee.com/platform/hive/ to schedule a demo.

About Trialbee

Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option. Founded in 2010, Trialbee has continuously innovated patient-centric technology solutions for global clinical trials. Trialbee – Dedicated to patients; driven by science; and powered by data. For more information, visit trialbee.com and contact us at solutions@trialbee.com.

Contacts

Kristi Lee-John for Trialbee
Tel.: +1 919-270-8054
klee@crossroadsb2b.com

Source Business Wire Health: Pharmaceutical News Read More

Recent Articles